In contrast, a study of 324 patients with acute myeloid leukemia (AML) found that CPT1B was significantly higher in AML patients than in the general population, and 324 clinical patient cases showed that this result often indicated shorter survival [97]. Here, CPT1B is linked to acute myeloid leukemia.